Correlation Between Karyopharm Therapeutics and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karyopharm Therapeutics and Mereo BioPharma Group, you can compare the effects of market volatilities on Karyopharm Therapeutics and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Mereo BioPharma.
Diversification Opportunities for Karyopharm Therapeutics and Mereo BioPharma
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Karyopharm and Mereo is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Mereo BioPharma go up and down completely randomly.
Pair Corralation between Karyopharm Therapeutics and Mereo BioPharma
Given the investment horizon of 90 days Karyopharm Therapeutics is expected to under-perform the Mereo BioPharma. In addition to that, Karyopharm Therapeutics is 1.24 times more volatile than Mereo BioPharma Group. It trades about -0.05 of its total potential returns per unit of risk. Mereo BioPharma Group is currently generating about 0.03 per unit of volatility. If you would invest 360.00 in Mereo BioPharma Group on September 26, 2024 and sell it today you would earn a total of 21.00 from holding Mereo BioPharma Group or generate 5.83% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Karyopharm Therapeutics vs. Mereo BioPharma Group
Performance |
Timeline |
Karyopharm Therapeutics |
Mereo BioPharma Group |
Karyopharm Therapeutics and Mereo BioPharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Karyopharm Therapeutics and Mereo BioPharma
The main advantage of trading using opposite Karyopharm Therapeutics and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
Mereo BioPharma vs. Fate Therapeutics | Mereo BioPharma vs. Caribou Biosciences | Mereo BioPharma vs. Karyopharm Therapeutics | Mereo BioPharma vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |